← sources

IBM 10-Q:

source: edgar (edgar_10q)published 2026-10-22 00:00ingested 2026-10-24 11:18

extract

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTER ENDED SEPTEMBER 30, 2026 1-2360 (Commission file number) INTERNATIONAL BUSINESS MACHINES CORPORATION (Exact name of registrant as specified in its charter) New York 13-0871985 (State of incorporation) (IRS employer identification number) One New Orchard Road 10504 Armonk, New York (Zip Code) (Address of principal executive offices) 914 - 499-1900 (Registrant’s telephone number) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Capital stock, par value $.20 per share IBM New York Stock Exchange ───────────────────────────────────────────────────────────────────────────────────────────────────────────────── NYSE Texas 0.300% Notes due 2026 IBM 26B New York Stock Exchange 1.250% Notes due 2027 IBM 27B New York Stock Exchange 3.375% Notes due 2027 IBM 27F New York Stock Exchange 0.300% Notes due 2028 IBM 28B New York Stock Exchange 1.750% Notes due 2028 IBM 28A New York Stock Exchange 1.500% Notes due 2029 IBM 29 New York Stock Exchange 0.875% Notes due 2030 IBM 30A New York Stock Exchange 2.900% Notes due 2030 IBM 30C New York Stock Exchange 1.750% Notes due 2031 IBM 31 New York Stock Exchange 3.000% Notes due 2031 IBM 31A New York Stock Exchange 3.625% Notes due 2031 IBM 31B New York Stock Exchange 0.650% Notes due 2032 IBM 32A New York Stock Exchange 3.150% Notes due 2033 IBM 33A New York Stock Exchange 3.450% Notes due 2034 IBM 34A New York Stock Exchange 1.250% Notes due 2034 IBM 34 New York Stock Exchange 3.750% Notes due 2035 IBM 35 New York Stock Exchange 3.450% Notes due 2037 IBM 37 New York Stock Exchange 3.850% Notes due 2038 IBM 38B New York Stock Exchange 4.875% Notes due 2038 IBM 38 New York Stock Exchange 1.200% Notes due 2040 IBM 40 New York Stock Exchange 4.000% Notes due 2043 IBM 43 New York Stock Exchange 3.800% Notes due 2045 IBM 45A New York Stock Exchange Floating Rate Notes due 2028 IBM 28E New York Stock Exchange 6.22% Debentures due 2027 IBM 27 New York Stock Exchange 6.50% Debentures due 2028 IBM 28 New York Stock Exchange 5.875% Debentures due 2032 IBM 32D New York Stock Exchange 7.00% Debentures due 2045 IBM 45 New York Stock Exchange 7.125% Debentures due 2096 IBM 96 New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer ☐ Smaller reporting company ☐ Non-accelerated filer Emerging growth company ☐ ───────────────────────────────────────────────────────────────────────────────────── If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ The registrant had 945,120,805 shares of common stock outstanding at September 30, 2026. Index Page Part I - Financial Information: Item 1. Consolidated Financial Statements (Unaudited): Consolidated Income Statement for the three and nine months ended September 30, 2026 and 2025 3 Consolidated Statement of Comprehensive Income for the three and nine months ended September 30, 2026 and 2025 4 Consolidated Balance Sheet at September 30, 2026 and December 31, 2025 5 Consolidated Statement of Cash Flows for the nine months ended September 30, 2026 and 2025 7 Consolidated Statement of Equity for the three and nine months ended September 30, 2026 and 2025 8 Notes to Consolidated Financial Statements 10 Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition 45 Item 4. Controls and Procedures 75 Part II - Other Information: Item 1. Legal Proceedings 76 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds and Issuer Repurchases of Equity Securities 76 Item 5. Other Information 76 Item 6. Exhibits 77 Table of Contents Part I - Financial Information Item 1. Consolidated Financial Statements: INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES CONSOLIDATED INCOME STATEMENT (UNAUDITED) Three Months Ended September 30, Nine Months Ended September 30, ($ and shares in millions, except per share amounts) 2026 2025 2026 2025 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Revenue: Services $ 8,000 $ 7,724 $ 23,615 $ 22,686 Sales 8,912 8,407 25,970 24,606 Financing 192 200 598 557 Total revenue 17,103 16,331 50,182 47,849 Cost: Services 5,441 5,224 15,979 15,506 Sales 1,834 1,637 5,287 4,672 Financing 114 109 345 303 Total cost 7,389 6,970 21,611 20,481 Gross profit 9,714 9,360 28,571 27,369 Expense and other (income): Selling, general and administrative 4,620 4,748 14,691 14,661 Research and development 2,378 2,082 6,863 6,129 Intellectual property and custom development income (164) (219) (501) (687) Other (income) and expense (109) (173) (296) (376) Interest expense 491 492 1,451 1,457 Total expense and other (income) 7,217 6,931 22,208 21,184 Income from continuing operations before income taxes 2,497 2,430 6,363 6,185 Provision for/(benefit from) income taxes 298 686 782 1,193 Income from continuing operations 2,199 1,744 5,581 4,992 Income/(loss) from discontinued operations, net of tax (10) 0 (10) 1 Net income $ 2,190 $ 1,744 $ 5,571 $ 4,993 Earnings/(loss) per share of common stock: Assuming dilution: Continuing operations $ 2.31 $ 1.84 $ 5.86 $ 5.27 Discontinued operations (0.01) 0.00 (0.01) 0.00 Total $ 2.30 $ 1.84 $ 5.85 $ 5.27 Basic: Continuing operations $ 2.33 $ 1.87 $ 5.93 $ 5.36 Discontinued operations (0.01) 0.00 (0.01) 0.00 Total $ 2.32 $ 1.87 $ 5.92 $ 5.36 Weighted-average number of common shares outstanding: Assuming dilution 953.5 948.9 953.0 947.4 Basic 944.4 933.9 941.4 930.9 (Amounts may not add due to rounding.) (The accompanying notes are an integral part of the financial statements.) Table of Contents INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED) Three Months Ended September 30, Nine Months Ended September 30, ($ in millions) 2026 2025 2026 2025 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Net income $ 2,190 $ 1,744 $ 5,571 $ 4,993 Other comprehensive income/(loss), before tax: Foreign currency translation adjustments 79 (100) 206 (1,056) Net unrealized gains/(losses) on available-for-sale securities 0 (2) 0 1 Unrealized gains/(losses) on cash flow hedges: Unrealized gains/(losses) arising during the period (66) 20 (123) (121) Reclassification of (gains)/losses to net income 5 94 443 (649) Total unrealized gains/(losses) on cash flow hedges (61) 113 321 (769) Retirement-related benefit plans: Prior service costs/(credits) — 0 — 0 Net gains/(losses) arising during the period (2) 0 (1) 0 Curtailments and settlements 2 2 7 8 Amortization of prior service costs/(credits) 9 (2) 26 (5) Amortization of net (gains)/losses 196 158 590 466 Total retirement-related benefit plans 205 158 622 469 Other comprehensive income/(loss), before tax 222 170 1,148 (1,355) Income tax (expense)/benefit related to items of other comprehensive income (56) (112) (420) 641 Other comprehensive income/(loss), net of tax 166 58 728 (715) Total comprehensive income $ 2,356 $ 1,802 $ 6,299 $ 4,278 (Amounts may not add due to rounding.) (The accompanying notes are an integral part of the financial statements.) INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES CONSOLIDATED BALANCE SHEET (UNAUDITED) ASSETS ($ in millions) At September 30, 2026 At December 31, 2025 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Assets: Current assets: Cash and cash equivalents $ 9,233 $ 13,587 Restricted cash 48 54 Marketable securities 1,825 830 Notes and accounts receivable — trade (net of allowances of $115 in 2026 and $99 in 2025) 5,794 8,112 Short-term financing receivables: Held for investment (net of allowances of $92 in 2026 and $106 in 2025) 5,638 7,344 Held for sale 774 1,131 Other accounts receivable (net of allowances of $29 in 2026 and $37 in 2025) 1,673 1,052 Inventory, at lower of average cost or net realizable value: Finished goods 320 230 Work in process and raw materials 1,625 990 Total inventory 1,945 1,220 Deferred costs 1,177 1,084 Prepaid expenses and other current assets 3,083 2,530 Total current assets 31,192 36,944 Property, plant and equipment 17,692 17,874 Less: Accumulated depreciation 11,649 11,975 Property, plant and equipment — net 6,043 5,899 Operating right-of-use assets — net 3,114 3,129 Long-term financing receivables (net of allowances of $28 in 2026 and $34 in 2025) 6,844 7,708 Prepaid pension assets 7,715 7,544 Deferred costs 808 825 Deferred taxes 8,827 8,610 Goodwill 74,916 67,717 Intangible assets — net 13,603 11,391 Investments and sundry assets 1,950 2,112 Total assets $ 155,011 $ 151,880 (Amounts may not add due to rounding.) (The accompanying notes are an integral part of the financial statements.) INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES CONSOLIDATED BALANCE SHEET - (CONTINUED) (UNAUDITED) LIABILITIES AND EQUITY ($ and shares in millions, except per share amount) At September 30, 2026 At December 31, 2025 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Liabilities: Current liabilities: Taxes $ 1,867 $ 2,347 Short-term debt 7,013 6,424 Accounts payable 4,491 4,756 Compensation and benefits 3,668 4,114 Deferred income 15,164 16,101 Operating lease liabilities 749 800 Other accrued expenses and liabilities 3,534 4,116 Total current liabilities 36,485 38,658 Long-term debt 56,804 54,836 Retirement and nonpension postretirement benefit obligations 8,452 9,018 Deferred income 4,318 4,271 Operating lease liabilities 2,574 2,547 Other liabilities 10,172 9,810 Total liabilities $ 118,805 $ 119,139 Equity: IBM stockholders’ equity: Common stock, par value $0.20 per share, and additional paid-in capital 65,137 63,318 Shares authorized: 4,688 Shares issued: 2026 — 2,300 2025 — 2,291 Retained earnings 156,576 155,648 Treasury stock - at cost (171,191) (170,605) Shares: 2026 — 1,355 2025 — 1,354 Accumulated other comprehensive income/(loss) (14,985) (15,713) Total IBM stockholders’ equity 35,537 32,648 Noncontrolling interests 669 93 Total equity 36,206 32,740 Total liabilities and equity $ 155,011 $ 151,880 (Amounts may not add due to rounding.) (The accompanying notes are an integral part of the financial statements.) INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) Nine Months Ended September 30, ($ in millions) 2026 2025 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Cash flows from operating activities: Net income $ 5,571 $ 4,993 Adjustments to reconcile net income to cash provided by operating activities: Depreciation (1) 1,638 1,698 Amortization of capitalized software and acquired intangible assets 2,363 2,027 Stock-based compensation 1,539 1,285 Net (gain)/loss on divestitures, asset sales and other (124) (46) Changes in operating assets and liabilities, net of acquisitions/divestitures 804 (804) Net cash provided by operating activities 11,791 9,153 Cash flows from investing activities: Payments for property, plant and equipment (793) (709) Proceeds from disposition of property, plant and equipment/other 60 118 Investment in software (467) (476) Purchases of marketable securities and other investments (4,769) (8,910) Proceeds from disposition of marketable securities and other investments 3,763 6,162 Acquisition of businesses, net of cash acquired (11,364) (7,903) Divestiture of businesses, net of cash transferred 30 (1) Net cash provided by/(used in) investing activities (13,539) (11,719) Cash flows from financing activities: Proceeds from new debt 9,415 8,391 Payments to settle debt (7,261) (3,679) Short-term borrowings/(repayments) less than 90 days — net 3 (29) Common stock repurchases for tax withholdings (817) (851) Proceeds from issuance of shares 562 535 Noncontrolling interest transactions (2) (3) 557 (15) Financing — other (2) (98) (93) Cash dividends paid (4,762) (4,681) Net cash provided by/(used in) financing activities (2,402) (423) Effect of exchange rate changes on cash, cash equivalents and restricted cash (209) 429 Net change in cash, cash equivalents and restricted cash (4,359) (2,561) Cash, cash equivalents and restricted cash at January 1 13,640 14,160 Cash, cash equivalents and restricted cash at September 30 $ 9,282 $ 11,600 (1) Includes operating lease right-of-use assets amortization expense of $0.6 billion in 2026 and2025. (2) Prior-year amounts have been reclassified to conform to the change in 2026 presentation. (3) Refer to "Other Transactions" in note 5, "Acquisition, Divestitures and Other Transactions," for additional information. (Amounts may not add due to rounding.) (The accompanying notes are an integral part of the financial statements.) INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES CONSOLIDATED STATEMENT OF EQUITY (UNAUDITED) ($ in millions, except per share amount) Common Retained Treasury Accumulated Total IBM Non- Total Stock and Earnings Stock Other Stockholders' Controlling Equity Additional Comprehensive Equity Interests Paid-in Income/(Loss) Capital ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Equity – July 1, 2026 $64,600 $ 155,937 $ (170,934) $ (15,151) $ 34,452 $89 $ 34,541 Net income plus other comprehensive income/(loss): Net income 2,190 2,190 2,190 Other comprehensive income/(loss) 166 166 166 Total comprehensive income $ 2,356 $ 2,356 Cash dividends paid — common stock ($1.69 per share) (1,596) (1,596) (1,596) Common stock issued under employee plans 537 537 537 Purchases and sales of treasury stock under employee plans — net 45 (257) (211) (211) Changes in noncontrolling interests (1) 580 580 Equity – September 30, 2026 $65,137 $ 156,576 $ (171,191) $ (14,985) $ 35,537 $669 $ 36,206 ($ in millions, except per share amount) Common Retained Treasury Accumulated Total IBM Non- Total Stock and Earnings Stock Other Stockholders' Controlling Equity Additional Comprehensive Equity Interests Paid-in Income/(Loss) Capital ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Equity – July 1, 2025 $62,392 $ 151,367 $ (170,209) $ (16,041) $ 27,509 $79 $ 27,588 Net income plus other comprehensive income/(loss): Net income 1,744 1,744 1,744 Other comprehensive income/(loss) 58 58 58 Total comprehensive income $ 1,802 $ 1,802 Cash dividends paid — common stock ($1.68 per share) (1,569) (1,569) (1,569) Common stock issued under employee plans 427 427 427 Purchases and sales of treasury stock under employee plans — net 39 (303) (263) (263) Changes in noncontrolling interests 6 6 Equity – September 30, 2025 $62,819 $ 151,581 $ (170,512) $ (15,983) $ 27,905 $85 $ 27,990 (1) Refer to "Other Transactions" in note 5, "Acquisition, Divestitures and Other Transactions," for additional information. (Amounts may not add due to rounding.) (The accompanying notes are an integral part of the financial statements.) INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES CONSOLIDATED STATEMENT OF EQUITY - (CONTINUED) (UNAUDITED) ($ in millions, except per share amount) Common Retained Treasury Accumulated Total IBM Non- Total Stock and Earnings Stock Other Stockholders' Controlling Equity Additional Comprehensive Equity Interests Paid-in Income/(Loss) Capital ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Equity – January 1, 2026 $ 63,318 $ 155,648 $ (170,605) $ (15,713) $ 32,648 $93 $ 32,740 Net income plus other comprehensive income/(loss): Net income 5,571 5,571 5,571 Other comprehensive income/(loss) 728 728 728 Total comprehensive income $ 6,299 $ 6,299 Cash dividends paid — common stock ($5.06 per share) (4,762) (4,762) (4,762) Common stock issued under employee plans 1,821 1,821 1,821 Purchases and sales of treasury stock under employee plans — net 119 (586) (467) (467) Other equity (1) 0 (1) (1) Changes in noncontrolling interests (1) 576 576 Equity – September 30, 2026 $ 65,137 $ 156,576 $ (171,191) $ (14,985) $ 35,537 $669 $ 36,206 ($ in millions, except per share amount) Common Retained Treasury Accumulated Total IBM Non- Total Stock and Earnings Stock Other Stockholders' Controlling Equity Additional Comprehensive Equity Interests Paid-in Income/(Loss) Capital ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Equity – January 1, 2025 $61,380 $ 151,163 $ (169,968) $ (15,269) $ 27,307 $86 $ 27,393 Net income plus other comprehensive income/(loss): Net income 4,993 4,993 4,993 Other comprehensive income/(loss) (715) (715) (715) Total comprehensive income $ 4,278 $ 4,278 Cash dividends paid — common stock ($5.03 per share) (4,681) (4,681) (4,681) Common stock issued under employee plans 1,439 1,439 1,439 Purchases and sales of treasury stock under employee plans — net 107 (544) (437) (437) Changes in noncontrolling interests (1) (1) Equity – September 30, 2025 $62,819 $ 151,581 $ (170,512) $ (15,983) $ 27,905 $85 $ 27,990 (1) Refer to "Other Transactions" in note 5, "Acquisition, Divestitures and Other Transactions," for additional information. (Amounts may not add due to rounding.) (The accompanying notes are an integral part of the financial statements.) Notes to Consolidated Financial Statements 1 1. Basis of Presentation: The accompanying Consolidated Financial Statements and footnotes of the International Business Machines Corporation (IBM or the company) have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The financial statements and footnotes are unaudited. In the opinion of the company’s management, these statements include all adjustments, which are only of a normal recurring nature, necessary to present a fair statement of the company’s results of operations, financial position and cash flows. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses and other comprehensive income/(loss) that are reported in the Consolidated Financial Statements and accompanying disclosures. These estimates are based on management’s best knowledge of current events, historical experience, actions that the company may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results may be different from these estimates. Noncontrolling interest amounts that impact the Consolidated Income Statement are included as a reduction within other (income) and expense and were not material to the consolidated results for the periods presented. Interim results are not necessarily indicative of financial results for a full year. The information included in this Form 10-Q should be read in conjunction with the company’s 2025 Annual Report. Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages presented are calculated from the underlying whole-dollar amounts. Certain prior-period amounts have been reclassified to conform to the change in current-period presentation. This is annotated where applicable. 2. Accounting Changes: New Standards to be Implemented Accounting for Government Grants Received by Business Entities Standard/Description - Issuance date: December 2025. This guidance establishes the accounting for government grants received by business entities and permits recognition when it is probable that the entity will comply with the grant's conditions and the grant will be received. The guidance also establishes presentation requirements for asset-related and income-related grants

retained text (truncated)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTER ENDED SEPTEMBER 30, 2026

1-2360

(Commission file number)

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

  New York                                      13-0871985
  (State of incorporation)                      (IRS employer identification number)
  One New Orchard Road                          10504
  Armonk, New York                              (Zip Code)
  (Address of principal executive offices)

914 - 499-1900

(Registrant’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

  Title of each class                          Trading symbol(s)      Name of each exchange on which registered
  Capital stock, par value $.20 per share      IBM                    New York Stock Exchange
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                                      NYSE Texas
  0.300% Notes due 2026                        IBM 26B                New York Stock Exchange
  1.250% Notes due 2027                        IBM 27B                New York Stock Exchange
  3.375% Notes due 2027                        IBM 27F                New York Stock Exchange
  0.300% Notes due 2028                        IBM 28B                New York Stock Exchange
  1.750% Notes due 2028                        IBM 28A                New York Stock Exchange
  1.500% Notes due 2029                        IBM 29                 New York Stock Exchange
  0.875% Notes due 2030                        IBM 30A                New York Stock Exchange
  2.900% Notes due 2030                        IBM 30C                New York Stock Exchange
  1.750% Notes due 2031                        IBM 31                 New York Stock Exchange
  3.000% Notes due 2031                        IBM 31A                New York Stock Exchange
  3.625% Notes due 2031                        IBM 31B                New York Stock Exchange
  0.650% Notes due 2032                        IBM 32A                New York Stock Exchange
  3.150% Notes due 2033                        IBM 33A                New York Stock Exchange
  3.450% Notes due 2034                        IBM 34A                New York Stock Exchange
  1.250% Notes due 2034                        IBM 34                 New York Stock Exchange
  3.750% Notes due 2035                        IBM 35                 New York Stock Exchange
  3.450% Notes due 2037                        IBM 37                 New York Stock Exchange
  3.850% Notes due 2038                        IBM 38B                New York Stock Exchange
  4.875% Notes due 2038                        IBM 38                 New York Stock Exchange
  1.200% Notes due 2040                        IBM 40                 New York Stock Exchange
  4.000% Notes due 2043                        IBM 43                 New York Stock Exchange
  3.800% Notes due 2045                        IBM 45A                New York Stock Exchange
  Floating Rate Notes due 2028                 IBM 28E                New York Stock Exchange
  6.22% Debentures due 2027                    IBM 27                 New York Stock Exchange
  6.50% Debentures due 2028                    IBM 28                 New York Stock Exchange
  5.875% Debentures due 2032                   IBM 32D                New York Stock Exchange
  7.00% Debentures due 2045                    IBM 45                 New York Stock Exchange
  7.125% Debentures due 2096                   IBM 96                 New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

  Large accelerated filer      Accelerated filer ☐      Smaller reporting company ☐
  Non-accelerated filer                                 Emerging growth company ☐
 ─────────────────────────────────────────────────────────────────────────────────────

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The registrant had 945,120,805 shares of common stock outstanding at September 30, 2026.

Index

                                                                                                                       Page
  Part I - Financial Information:
  Item 1. Consolidated Financial Statements (Unaudited):
  Consolidated Income Statement for the three and nine months ended September 30, 2026 and 2025                           3
  Consolidated Statement of Comprehensive Income for the three and nine months ended September 30, 2026 and 2025          4
  Consolidated Balance Sheet at September 30, 2026 and December 31, 2025                                                  5
  Consolidated Statement of Cash Flows for the nine months ended September 30, 2026 and 2025                              7
  Consolidated Statement of Equity for the three and nine months ended September 30, 2026 and 2025                        8
  Notes to Consolidated Financial Statements                                                                             10
  Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition                          45
  Item 4. Controls and Procedures                                                                                        75
  Part II - Other Information:
  Item 1. Legal Proceedings                                                                                              76
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds and Issuer Repurchases of Equity Securities        76
  Item 5. Other Information                                                                                              76
  Item 6. Exhibits                                                                                                       77

Table of Contents

Part I - Financial Information

Item 1. Consolidated Financial Statements:

INTERNATIONAL BUSINESS MACHINES CORPORATION

AND SUBSIDIARY COMPANIES

CONSOLIDATED INCOME STATEMENT

(UNAUDITED)

                                                              Three Months Ended September 30,                                         Nine Months Ended September 30,
  ($ and shares in millions, except per share amounts)        2026                                              2025                   2026                                             2025
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Revenue:
  Services                                                    $                                      8,000      $           7,724      $                                    23,615      $          22,686
  Sales                                                                                              8,912                  8,407                                           25,970                 24,606
  Financing                                                   192                                               200                    598                                              557
  Total revenue                                                                                     17,103                 16,331                                           50,182                 47,849
  Cost:
  Services                                                                                           5,441                  5,224                                           15,979                 15,506
  Sales                                                                                              1,834                  1,637                                            5,287                  4,672
  Financing                                                   114                                               109                    345                                              303
  Total cost                                                                                         7,389                  6,970                                           21,611                 20,481
  Gross profit                                                                                       9,714                  9,360                                           28,571                 27,369
  Expense and other (income):
  Selling, general and administrative                                                                4,620                  4,748                                           14,691                 14,661
  Research and development                                                                           2,378                  2,082                                            6,863                  6,129
  Intellectual property and custom development income         (164)                                             (219)                  (501)                                            (687)
  Other (income) and expense                                  (109)                                             (173)                  (296)                                            (376)
  Interest expense                                            491                                               492                                                          1,451                  1,457
  Total expense and other (income)                                                                   7,217                  6,931                                           22,208                 21,184
  Income from continuing operations before income taxes                                              2,497                  2,430                                            6,363                  6,185
  Provision for/(benefit from) income taxes                   298                                               686                    782                                                          1,193
  Income from continuing operations                                                                  2,199                  1,744                                            5,581                  4,992
  Income/(loss) from discontinued operations, net of tax      (10)                                              0                      (10)                                             1
  Net income                                                  $                                      2,190      $      

document fetched 2026-10-24 11:18 · canonical https://sec.gov/Archives/edgar/data/51143/000005114326000095/ibm-20260930.htm